AUTOIMMUNE-THROMBOCYTOPENIA AND SLE IN A PATIENT WITH 5Q-ANOMALY AND DELETION OF THE C-FMS ONCOGENE

被引:13
作者
JAEGER, U
PANZER, S
BARTRAM, C
HAAS, O
VOLCPLATZER, B
GRANINGER, W
GEISSLER, K
RADASZKIEWICZ, T
LECHNER, K
机构
[1] UNIV VIENNA,ST ANNA CHILDRENS HOSP,DIV HAEMATOL,A-1010 VIENNA,AUSTRIA
[2] UNIV VIENNA,ST ANNA CHILDRENS HOSP,DIV DERMATOL,A-1010 VIENNA,AUSTRIA
[3] UNIV VIENNA,ST ANNA CHILDRENS HOSP,DIV CHEMOTHERAPY,A-1010 VIENNA,AUSTRIA
[4] UNIV VIENNA,ST ANNA CHILDRENS HOSP,DIV PATHOL,A-1010 VIENNA,AUSTRIA
[5] DEPT PEDIAT 2,ULM,GERMANY
关键词
MYELODYSPLASTIC SYNDROME; IMMUNOLOGICAL PHENOMENA; SLE;
D O I
10.1002/ajh.2830450112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoimmune-thrombocytopenia was the striking feature in a patient with typical clinical symptoms of systemic lupus erythematosus (SLE), complement C4 deficiency, and positive lupus serology. However, myelodysplasia was found in the bone marrow and chromosome analysis revealed a deletion of the long arm of chromosome 5 (5q - anomaly), which was confirmed by a hemizygosity for the c-fms oncogene (CSF-1-receptor) on Southern blot. Autoimmune phenomena reported in conjunction with myelodysplastic syndromes (MDS), e.g., an elevation of antinuclear antibodies, are usually regarded as nonspecific. This case report suggests that SLE can occur in patients with MDS and that a concomitant autoimmune-thrombocytopenia may mask the typical signs of the 5q- syndrome. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:79 / 80
页数:2
相关论文
共 10 条
[1]  
ANDERSON MJ, 1985, ARTHRITIS RHEUM, V25, P1271
[2]   SIDEROBLASTIC REFRACTORY ANEMIA IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BALLAS, SK .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1973, 265 (03) :225-231
[3]  
BARTRAM R, 1992, HAEMATOL ONCOL CLIN, V6, P557
[4]   THE 5Q- CHROMOSOME ABNORMALITY IN HEMATOLOGICAL DISORDERS - A COLLABORATIVE STUDY OF 34 CASES FROM THE NETHERLANDS [J].
KERKHOFS, H ;
HAGEMEIJER, A ;
LEEKSMA, CHW ;
ABELS, J ;
DENOTTOLANDER, GJ ;
SOMERS, R ;
GERRITS, WBJ ;
LANGENHUIYEN, MMAC ;
BORNE, V ;
VANHEMEL, JO ;
GERAEDTS, JPM .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 52 (03) :365-381
[5]   THE MYELODYSPLASTIC SYNDROMES - BIOLOGY AND IMPLICATIONS FOR MANAGEMENT [J].
LIST, AF ;
GAREWAL, HS ;
SANDBERG, AA .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1424-1441
[6]   IMMUNOLOGICAL ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES .1. SERUM IMMUNOGLOBULINS AND AUTOANTIBODIES [J].
MUFTI, GJ ;
FIGES, A ;
HAMBLIN, TJ ;
OSCIER, DG ;
COPPLESTONE, JA .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 63 (01) :143-147
[7]  
STADTMAUER E, 1988, BLOOD S, V72, pA299
[8]   SPECIAL ARTICLE - THE 1982 REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
TAN, EM ;
COHEN, AS ;
FRIES, JF ;
MASI, AT ;
MCSHANE, DJ ;
ROTHFIELD, NF ;
SCHALLER, JG ;
TALAL, N ;
WINCHESTER, RJ .
ARTHRITIS AND RHEUMATISM, 1982, 25 (11) :1271-1277
[9]   THE 5Q- ANOMALY [J].
VANDENBERGHE, H ;
VERMAELEN, K ;
MECUCCI, C ;
BARBIERI, D ;
TRICOT, G .
CANCER GENETICS AND CYTOGENETICS, 1985, 17 (03) :189-255
[10]  
WISNJEWSKI LP, 1985, AM J HEMATOL, V15, P295